Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Front Psychiatry ; 12: 738579, 2021.
Article in English | MEDLINE | ID: mdl-34658972

ABSTRACT

Objective: To examine the efficacy and the role of engagement of an internet-based Mindfulness-based Stress Reduction (iMBSR) for survivors of breast cancer (BC) during the COVID-19 period from January to March in 2020 in China. Methods: 48 survivors of BC were divided into the absentees group and the iMBSR groups according to their attending to the standardized, group-based, 8-week iMBSR. Based on practice time, survivors of BC in the iMBSR were categorized into three subgroups: group 1 (<30 min/day), group 2 (30-60 min/day), and group 3 (>60 min/day). In addition, participants were classified as partial attendees (<4 sessions) and completers (more than 4 sessions) of the iMBSR groups. All participants were evaluated for symptoms of depression, anxiety and insomnia at baseline, mid-intervention, and post-intervention. Results: After an 8-week iMBSR practice, at mid-intervention and post-intervention, participants in iMBSR group had significant improvement in scores and reduction rates of depression, anxiety, and insomnia compared to absentees. Scores of depression and insomnia, reduction rates of depression at post-intervention, scores of anxiety, reduction rates of anxiety and insomnia at mid-intervention and post-intervention, had significant differences among subgroups of practice time. Daily practice time was positively related to reduction rates of depression, anxiety and insomnia at post-intervention in the iMBSR group. Conclusion: Internet-based MBSR showed efficacy in reducing psychological symptoms among survivors of BC. For survivors of BC, iMBSR practice has a potential dose-response efficacy, with a threshold of >30 min daily practice for most optimal symptoms reduction. Trial Registration: Registration number is [ChiCTR2100044309].

2.
J Biomed Nanotechnol ; 14(9): 1568-1577, 2018 Sep 01.
Article in English | MEDLINE | ID: mdl-29958551

ABSTRACT

In order to improve the anti-cancer therapy efficiency of hydrophobic drugs such as curcumin (Cur), a novel dual pH/redox sensitive marine laminarin-based nanomedicine carrier biomaterial with photo-dynamic therapy (PDT) was synthesized in this study. The new synthetic chemical structure, named as Hematin-Laminarin-Dithiodipropionic Acid-MGK (HLDM), was characterized by 1H-NMR and IR. The Cur-loaded micelles were then prepared via dialysis method. The HLDM could self-assemble into micelles in water with hydrodynamic diameter of 135±15 nm. The particle size, zeta potential and morphology of micelles were detected by transmission electron microscope (TEM). Interestingly, the in vitro release experiment showed that the release amount of Cur-loaded HLDM micelles could reach 80% in the pH and redox sensitive environment. Furthermore, cell study showed that the Cur-loaded HLDM micelles had stronger cellular uptake and cytotoxicity to MCF-7 cells than that of HLDM. The multifunctional marine laminarin based nanomedicine carrier biomaterial can be used for new drug delivery systems with dual pH/redox sensitivity for cancer therapy.


Subject(s)
Glucans/chemistry , Antineoplastic Agents , Biocompatible Materials , Curcumin , Drug Carriers , Hydrogen-Ion Concentration , Micelles , Nanomedicine , Oxidation-Reduction , Particle Size
3.
Food Chem Toxicol ; 48(10): 2988-93, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20678537

ABSTRACT

Previous nephrotoxicology study on Morning Glory Seed (MGS) mainly focused on whole animal level, using creatinine and BUN as biochemical indicators to evaluate renal function. This work was designed to delineate the comprehensive metabolic syndromes of MGS-induced nephrotoxicity. An ultra liquid chromatography coupled with mass spectrometry (UPLC/MS) metabonomic approach was employed to characterize the metabolic profile of plasma and kidney tissue extract from rats treated with MGS at a single nephrotoxic dose of 15 g/kg/day for 14 consecutive days. Acquired data were subjected to principal component analysis (PCA) for differentiating the model and the control groups. The results indicated that certain metabolic pathways, such as lysophosphatidylcholines formation and sphingolipids cycle were accelerated, while the phenylalanine level in serum was decreased. We believe that metabonomic approach is helpful to further understanding and clinical diagnosis of traditional Chinese medicine (TCM) induced nephrotoxicity.


Subject(s)
Ipomoea/toxicity , Kidney Diseases/blood , Kidney Diseases/chemically induced , Kidney/drug effects , Kidney/metabolism , Animals , Biomarkers , Chromatography, High Pressure Liquid , Drugs, Chinese Herbal/toxicity , Indicators and Reagents , Kidney/pathology , Kidney Diseases/pathology , Lysophosphatidylcholines/metabolism , Male , Mass Spectrometry , Phenylalanine/blood , Phospholipids/metabolism , Rats , Rats, Wistar , Seeds/toxicity , Sphingolipids/metabolism
4.
J Ethnopharmacol ; 130(1): 134-42, 2010 Jul 06.
Article in English | MEDLINE | ID: mdl-20435118

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Morning Glory Seed (MGS) is a valuable traditional Chinese medicine which is widely used for the treatment of edema, ascites, hydroncus, simple obesity, lung fever and ardent fever. In recent years, long-term exposure to Morning Glory Seed (MGS) has shown to pose progressive renal damage in clinical practice. We hypothesize that changes in metabolic profile could have occurred before symptoms were observed, which may allow early treatment. AIM OF THE STUDY: To investigate the metabolic changes caused by Morning Glory Seed-induced renal damage. METHOD: Metabonomics method was used for chronic toxicology study of MGS in Wistar rats. With a therapeutic dose, the model rats were orally administered the extract of MGS for 10 weeks continuously. The urine samples of model and control rats were collected in various time-points and the endogenous metabolites were analyzed by ultraperformance liquid chromatography coupled with mass spectrometry. The identification of all the potential biomarkers was performed using reference standard by comparing their mass spectra, MS/MS fragmentation and retention time. Furthermore, histopathology and clinical chemistry studies were carried out to ensure the success of MGS-induced nephrotoxicity model. RESULTS: The difference in metabolic profiles between the control and the dosed rats was well observed by the principal component analysis (PCA) of the MS spectra. Significant changes of 12 metabolite biomarkers were detected in the rat urine samples. Metabonomics method could discriminate the model rats from the control rats in 2nd, 6th and 10th week respectively before serious organic damage of kidney was found in 10th week by histopathology method. CONCLUSION: We believe that metabolic profiling may act as a preclinical protocol for MGS exposure before symptoms are observed.


Subject(s)
Ipomoea/embryology , Metabolomics , Seeds/chemistry , Urinalysis , Animals , Biomarkers/metabolism , Chromatography, High Pressure Liquid , Principal Component Analysis , Rats , Rats, Wistar , Tandem Mass Spectrometry
5.
J Pharm Biomed Anal ; 53(3): 559-66, 2010 Nov 02.
Article in English | MEDLINE | ID: mdl-20403675

ABSTRACT

This paper was designed to study metabonomic characters of the nephrotoxicity induced by Morning Glory Seed (MGS), a well-known traditional Chinese medicine which was used for the treatment of edema, simple obesity and lung fever. Urinary samples from control and MGS treated rats were analyzed by ultra-performance liquid chromatography/mass spectrometry (UPLC-MS) in positive ionization mode. Blood biochemistry and histopathology were examined to identify specific changes of renal damage. The results affirmatively suggested that ethanol extract of Morning Glory Seed (EMGS), instead of water extract of Morning Glory Seed (WMGS), should be responsible for the nephrotoxicity caused by this herbal medicine. The UPLC-MS analysis revealed that the levels of 8 endogenous metabolites as biomarkers were significantly changed in urine from EMGS treated rats. The underlying regulations of EMGS-perturbed metabolic pathways were discussed according to the identified metabolites. The present study proves the potential of UPLC-MS based metabonomics in mapping metabolic response for toxicology.


Subject(s)
Ipomoea nil/toxicity , Kidney/drug effects , Medicine, Chinese Traditional , Metabolomics , Seeds/toxicity , Animals , Chromatography, High Pressure Liquid , Kidney/pathology , Male , Plant Extracts/toxicity , Rats , Rats, Wistar , Tandem Mass Spectrometry
SELECTION OF CITATIONS
SEARCH DETAIL